[Tuberculosis: Analysis of the history and development of multiple antibiotic resistance].

Yolanda Monserrath Jacobo-Delgado, Luis Adrián De Jesús-González, Bruno Rivas-Santiago
{"title":"[Tuberculosis: Analysis of the history and development of multiple antibiotic resistance].","authors":"Yolanda Monserrath Jacobo-Delgado, Luis Adrián De Jesús-González, Bruno Rivas-Santiago","doi":"10.5281/zenodo.13306769","DOIUrl":null,"url":null,"abstract":"<p><p>Tuberculosis is an ancient disease that has accompanied humanity for the last three thousand years and is considered the oldest infectious disease that still exists. The Mycobacterium tuberculosis bacillus was spread worldwide due to human migrations, and there is archaeological evidence of spinal tuberculosis cases in Egyptian and Andean mummies, as well as texts that attributed the disease to social factors before suspecting its infectious nature. Throughout its history, humans have dealt with this pathology by developing unusual and ineffective therapies, leading to a significant increase in the disease's mortality. In the past century, the first antibiotics were introduced, bringing hope to eradicate this disease. However, evolutionary pressure has led to the emergence of multi-drug-resistant strains. Today, the development of computational techniques, such as artificial intelligence, has given us new hope for generating drugs and potential immunomodulatory therapies. However, it is essential to remember that those who do not know their history are doomed to repeat it. In this review, we summarize the history of tuberculosis, analyzing theories of its possible origin, its discovery, the creation of the first empirical treatments, vaccines, the emergence of new antibiotics, and how the mycobacterium quickly develops resistance.</p>","PeriodicalId":94200,"journal":{"name":"Revista medica del Instituto Mexicano del Seguro Social","volume":"62 6","pages":"137"},"PeriodicalIF":0.0000,"publicationDate":"2024-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revista medica del Instituto Mexicano del Seguro Social","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5281/zenodo.13306769","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Tuberculosis is an ancient disease that has accompanied humanity for the last three thousand years and is considered the oldest infectious disease that still exists. The Mycobacterium tuberculosis bacillus was spread worldwide due to human migrations, and there is archaeological evidence of spinal tuberculosis cases in Egyptian and Andean mummies, as well as texts that attributed the disease to social factors before suspecting its infectious nature. Throughout its history, humans have dealt with this pathology by developing unusual and ineffective therapies, leading to a significant increase in the disease's mortality. In the past century, the first antibiotics were introduced, bringing hope to eradicate this disease. However, evolutionary pressure has led to the emergence of multi-drug-resistant strains. Today, the development of computational techniques, such as artificial intelligence, has given us new hope for generating drugs and potential immunomodulatory therapies. However, it is essential to remember that those who do not know their history are doomed to repeat it. In this review, we summarize the history of tuberculosis, analyzing theories of its possible origin, its discovery, the creation of the first empirical treatments, vaccines, the emergence of new antibiotics, and how the mycobacterium quickly develops resistance.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
[结核病:多种抗生素耐药性的历史和发展分析]。
结核病是一种古老的疾病,在过去的三千年里一直伴随着人类,被认为是现存的最古老的传染病。结核分枝杆菌因人类迁徙而传播到世界各地,埃及和安第斯木乃伊中有脊柱结核病例的考古证据,还有一些文献在怀疑该病的传染性之前将其归咎于社会因素。纵观历史,人类通过开发不同寻常且无效的疗法来应对这种病症,导致该疾病的死亡率大幅上升。上个世纪,第一批抗生素问世,为根除这种疾病带来了希望。然而,进化的压力导致了多重耐药菌株的出现。如今,人工智能等计算技术的发展给我们带来了生成药物和潜在免疫调节疗法的新希望。然而,我们必须牢记,不了解历史的人注定会重蹈覆辙。在这篇综述中,我们总结了结核病的历史,分析了结核病可能的起源理论、结核病的发现、首批经验疗法的诞生、疫苗、新型抗生素的出现以及分枝杆菌如何迅速产生抗药性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
[Epidemiological and clinical aspects of Guilain-Barré syndrome, 2012-2022]. [Erythrocyte morphological alterations as predictors of kidney injury severity]. [HIV mortality trends in Mexico, 2000-2022]. [Risk of postoperative delirium in older adults under balanced general anesthesia]. [Workplace violence as a predictor of suicidal ideation in undergraduate internal physicians].
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1